SW Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. SW is sitting just above near-term support (~40.87) with weakening momentum (bearish/expanding negative MACD) and notable hedge-fund selling. While options positioning is bullish (very low put/call open-interest ratio) and Street ratings remain mostly constructive, the price trend doesn’t yet confirm a reversal. For an impatient buyer who wants to enter immediately (no waiting), the current setup is not compelling enough versus the risk of a breakdown below support.
Price/levels: Post-market 41.63, below the pivot 42.46. Immediate support is S1 ~40.87 (then S2 ~39.88); resistance levels are ~44.06 and ~45.05. Momentum: MACD histogram -0.235 and negatively expanding signals bearish momentum is strengthening. RSI(6) ~38.5 is not deeply oversold, but shows weakness and a market that can still drift lower before mean-reverting. Moving averages are converging, which often precedes a larger directional move; combined with a bearish MACD and price below pivot, the bias is still down-to-sideways until SW reclaims ~42.5 and holds.
Intellectia Proprietary Trading Signals
Pattern-based projection (candlestick analogs): suggests a modest upward drift (model indicates positive odds over 1D/1W/1M), but this is currently fighting the bearish momentum indicators—so it’s a lower-conviction bounce setup unless support clearly holds.
Wall Street stance on SW remains broadly constructive: recent notes include Truist reiterating Buy (PT cut to $
and Barclays maintaining Overweight (PT cut to $47), and Morgan Stanley maintaining Overweight (slightly higher target in GBp).
Industry backdrop mentioned by analysts: potential for containerboard price increases supported by disciplined supply, and continued beverage can growth.
Technical setup is near support (40.9); if it holds, a mean-reversion bounce toward the pivot (42.
and then ~44 can occur quickly.
Next earnings (QDEC
on 2026-02-11 pre-market can act as a catalyst if margins/earnings stabilize versus the weak YoY net income/EPS comps.
Trend/momentum is currently bearish: expanding negative MACD and price below pivot increases odds of a support test/break.
Fund flows: Hedge funds are selling, with selling amount up ~200% QoQ—clear negative signal from institutional behavior.
Profitability optics: latest quarter shows a very large YoY drop in net income and EPS, which can keep a valuation/multiple lid on the stock until the market is confident it’s non-recurring.
No supportive news flow in the last week (no fresh positive catalyst to counter the technical weakness).
Latest reported quarter: 2025/Q3. Revenue grew to ~$8.003B (+4.33% YoY) and gross margin improved to ~19.61 (+11.42% YoY), indicating top-line resilience and some margin progress. However, net income fell to ~$246M (-264% YoY) and EPS to $0.47 (-256.67% YoY), a sharp profitability deterioration versus last year (likely driven by one-time items and/or integration/transition costs, but the market still has to digest it). Next earnings: QDEC 2025 on 2026-02-11 (pre-market), Street EPS est. ~0.45—this is the next major checkpoint for stabilization.
Recent SW-specific analyst changes show a pattern of maintained positive stances with lowered targets: Barclays (Overweight) cut PT to $47 from $63 (2025-11-10) and Truist (Buy) cut PT to $49 from $50 (2026-01-06), while Morgan Stanley kept Overweight and nudged its target up slightly (2026-01-08). Net takeaway: Wall Street ‘pros’ see medium-term upside/industry tailwinds, but the cons are tempered expectations and target cuts, implying near-term fundamentals/volumes and earnings quality are still a concern.
Influential/political trading: No recent congress trading data available; no notable politician/influential-figure transactions were provided. Insider activity is neutral (no significant recent trend).
